Oppenheimer & Co’s Verona Pharma VRNA Stock Holding History

Oppenheimer & Co’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,099	Closed	-$544K	–	1750
2025 Q3	$544K	Sell	5,099 -516	-9%	-$53.9K	0.01%	1145
2025 Q2	$531K	Buy	+5,615	New	+$416K	0.01%	1120

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Oppenheimer & Co's VRNA Position: Q4 2025 in Review

Oppenheimer & Co sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 5,099 shares — an estimated $544K sold.

Oppenheimer & Co first reported a position in VRNA in Q2 2025 and held it in 2 quarters. The position peaked at $544K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Oppenheimer & Co reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Oppenheimer & Co sold 5,099 Verona Pharma shares in Q4 2025, an estimated $544K.
Oppenheimer & Co first reported a position in Verona Pharma in Q2 2025 and held it in 2 quarters.
Oppenheimer & Co's Verona Pharma position peaked at $544K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Oppenheimer & Co's 13F filing for Q4 2025, filed 2 Feb 2026.